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ABSTRACT Glycine is a coagonist at the N-methyl-D-aspartate receptor. Changes in extracellular glycine concentration may
modulateN-methyl-D-aspartate receptor function and excitatory synaptic transmission. The GLYT1 glycine transporter is present
in glia surrounding excitatory synapses, and plays a key role in regulating extracellular glycine concentration. We investigated the
kinetic and other biophysical properties of GLYT1b, stably expressed in CHO cells, using whole-cell patch-clamp techniques.
Application of glycine produced an inward current, which decayed within a few seconds to a steady-state level. When glycine was
removed, a transient outward current was observed, consistent with reverse transport of accumulated glycine. Theoutward current
was enhanced by elevating intracellular or lowering extracellular [Na1], and was modulated by changes in extracellular [glycine]
and time of glycine application. We developed a model of GLYT1b function, which accurately describes the time course of the
transporter current under a range of experimental conditions. Themodel predicts that glial uptake of glycine will decay toward zero
during a sustained period of elevated glycine concentration. This property of GLYT1b may permit spillover from glycinergic
terminals to nearby excitatory terminals during a prolonged burst of inhibitory activity, and reverse transport may extend the period
of elevated glycine concentration beyond the end of the inhibitory burst.
INTRODUCTION
Glycine has two distinct roles in neurotransmission. It acts as
the main inhibitory neurotransmitter in the brain stem and
spinal cord (1), and as an excitatory coagonist with glutamate
at N-methyl-D-aspartate receptors (NMDARs) throughout
the brain (2). After glycine is released at an inhibitory syn-
apse, it is cleared by a combination of diffusion and reuptake
into the synaptic terminal, neighboring neurons, and glial
cells. Reuptake is performed by glycine transporters (GLYTs),
of which several subtypes have been identiﬁed. GLYT2 is
localized at inhibitory synaptic terminals, whereas GLYT1 is
present in glia, including those that surround excitatory syn-
apses (3,4). GLYT2 has a stoichiometry of 3 Na1/Cl/gly-
cine, which guarantees effective glycine accumulation under
all physiological conditions, whereas GLYT1 has a stoichi-
ometry of 2 Na1/Cl/glycine, and glycine will be exported
or imported depending on physiological conditions (5). No
glycine-containing vesicles, or vesicular uptake proteins,
are associated with excitatory presynaptic terminals (6–9).
Instead, glycine may be released into the synaptic cleft from
adjacent glia, via reverse transport through GLYT1 trans-
porters. Evidence for nonvesicular, Ca21-independent neu-
rotransmitter release has been reported for g-aminobutyric
acid (GABA) (10) and glutamate transporters (11) and is
reviewed in Attwell et al. (12). GLYT1-mediated glycine
release has recently been demonstrated in a neuronal prep-
aration (13), and GLYT1 can facilitate release of radio-
labeled glycine from cell lines (14–16); in addition, reverse
transport has been demonstrated in the oocyte expression
system (5).
For GLYT1-mediated glycine release to modulate excit-
atory synaptic transmission, the resting glycine concentra-
tion in the synaptic cleft must not saturate the binding site on
NMDARs. The minimum extracellular glycine concentra-
tion that GLYT1 can theoretically maintain (0.15 mM) is
below the EC50 at the NMDAR (0.6–1.7 mM) (17). Inhibi-
tion of GLYT1 increases extracellular glycine concentration
in the hippocampus of awake, freely moving rats (18). It also
enhances NMDAR mediated synaptic currents in hippocam-
pal pyramidal, prefrontal cortex, neonatal hypoglossal, and
spinal cord (lamina X) neurons in brain slice (19–22). Thus,
in some brain regions, GLYT1 maintains the glycine concen-
tration in the synaptic cleft below the level needed to saturate
NMDA receptors.
Glycine uptake by GLYT1 can downregulate excitatory
synaptic transmission, but could reverse transport by GLYT1
enhance excitatory transmission under some circumstances?
Reverse transport currents were observed in Xenopus laevis
oocytes expressing rat GLYT1b after prolonged exposure to
high levels of glycine (5). The current increased in amplitude
with longer periods of glycine uptake, and increased expo-
nentially with depolarization. Reapplying extracellular gly-
cine inhibited the current. It remains unclear whether reverse
transport through GLYT1b can inﬂuence extracellular gly-
cine concentrations on the synaptic timescale. In oocyte
recordings, the current lasts for several minutes, reﬂecting
glycine accumulation in a very large intracellular volume. It
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is probable that glycine efﬂux from small mammalian cells
will be more transient.
We investigated the kinetic and other biophysical
properties of GLYT1b stably transfected in Chinese hamster
ovary (CHO-GLYT1b) (23). Application of glycine pro-
duced an inward current that decayed to a steady-state level
over several seconds. When glycine was removed, a tran-
sient overshoot current was observed, consistent with re-
verse transport of accumulated glycine. The reverse transport
current was enhanced by elevating intracellular Na1, or by
lowering the extracellular Na1 concentration and modulated
by changes in extracellular glycine concentration as well as
by changing the time exposed to glycine. We developed
a model of GLYT1b, and the accumulation of glycine in a
CHO cell. The model accurately predicts the time course of
the transporter current under a range of experimental condi-
tions, and provides insights into the role of GLYT1b trans-
porters in modulating synaptic function.
MATERIALS AND METHODS
Cell culture media and solutions were supplied by GIBCO (Invitrogen,
Grand Island, NY). All other chemicals were obtained from Sigma
Chemicals (Sydney, Australia) unless otherwise stated. CHO-GLYT1b
were a gift from John Morrow at Organon Laboratories (Newhouse,
Scotland). N[3-(49-ﬂuorophenyl)-3-(49-phenylphenoxy)propyl]sarcosine
(NFPS) (also termed ALX-5407) was supplied by Allelix Neuroscience
(NPS Pharmaceuticals, Salt Lake City, UT). NFPS was made into a stock
solution of 1 mM in dimethylsulfoxide and diluted in to buffer as
appropriate. The maximum dimethylsulfoxide concentration applied to cells
was 0.1% (v/v), which did not generate a measurable current in
untransfected CHO-K1 cells nor inhibit glycine transport currents when
applied with glycine to CHO-GLYT1b cells.
Cell culture
CHO-GLYT1b cells were cultured in Dulbecco’s modiﬁed Eagle’s medium:
Ham’s F-12 nutrient mix (DMEM-F12) (1:1) media supplemented with 5%
fetal bovine serum (CSL Biosciences, Parkville, Australia) and 0.6 mg/ml
geneticin. Cells were incubated at 37C in a humidiﬁed chamber with 5%
CO2. Cells were grown to conﬂuence and passaged with trypsin-EDTA. Ex-
periments were performed 2–4 days after passage.
3H-Glycine uptake in CHO-GLYT1b cells
CHO-GLYT1b cells were passaged and plated out into 24 well plates
(CulturPlate-24, Packard Instruments, Downers Grove, IL) at a density of
403104 cells perwell and left to settle for 3h.Mediawere then removed and the
cells were washed once with Hanks’ buffer (37C) to remove residual media.
Uptake experiments were carried out at 37C in the presence of 30 mM 3H-
glycine for 20 min. 3H-glycine was applied alone or in the presence of NFPS
(1mM), a selective antagonist of GLYT1 transporters, or sarcosine (300mM),
a competitive substrate at GLYT1 transporters. NFPS acts slowly, so cells
were preincubated for 5 min before the addition of 3H-glycine. Background
3H-glycine uptake was measured in untransfected CHO-K1 cells under the
same conditions. Uptake was terminated by washing the cells twice with ice-
cold Hanks’ buffer, and cells were then lysed with 50 mM NaOH, and
scintillation ﬂuid (Ultima Gold, Packard Instruments) added. 3H-glycine
uptake was quantiﬁed in counts per minute using a Uniﬁlter-96 GF/C
microplate scintillation counter (Packard Instruments).
Whole-cell patch-clamp recordings of
CHO-GLYT1b cells
During whole-cell patch-clamp recordings, cell culture media were ex-
changed for an external salt solution containing in mM: NaCl 150; KCl 5;
CaCl2 2; MgCl2 5; HEPES 10; glucose 10; adjusted to pH 7.4 (with NaOH),
osmolality 320 mOsmol l1. In experiments where extracellular Na1 was
reduced, Na1 was substituted with equimolar choline chloride and pH was
adjusted with KOH. Micropipette recording electrodes were pulled from
borosilicate glass (1.5 mm outer diameter, 0.86 mm inner diameter, SDR
Clinical Technology, Sydney, Australia) on a horizontal puller (Sutter In-
struments, Navato, CA), ﬁre-polished to a ﬁnal resistance of 2–4 MOhm and
coated with SigmaCoat before use. Electrodes were ﬁlled with an internal
salt solution containing in mM: KCl 60; Kgluconate 80; CaCl2 0.2; EGTA
10; NaCl 5; HEPES 30; MgATP 5; adjusted to pH 7.4 (with KOH),
osmolality 295 mOsmol l1. In experiments where intracellular Na1 was
increased, it was done at the expense of equimolar K1. The intracellular Na1
concentration ([Na1]i) is indicated in mM on each ﬁgure accompanying this
article. In ﬁgures where the glycine gradient is altered, [glycine] is also indi-
cated in mM.
Whole-cell glycine transport currents were recorded from stably transfected
CHO-GLYT1b cells. Cells presented were voltage clamped at 0 mV; control
currents were also recorded at30 mV for each experiment. Glycine transport
currents were recorded using an Axopatch 200B ampliﬁer (Axon Instruments,
Molecular Devices, Union City, CA), with a CV203BU head stage (Axon
Instruments) and AxoGraph 4.8 (Axon Instruments) acquisition software.
Currents were low-pass ﬁltered at 2 kHz. During recording, extracellular
solution was delivered to the cell with a Warner Instruments (Hamden, CT)
SF-77B perfusion fast step system, which produced a solution exchange
time of ,100 ms. Series resistance (,8 MOhm) was compensated by 80%
and continuouslymonitored during experiments. Cell capacitancewas compen-
sated for manually by nulling capacitive transients evoked by applying a 5 mV
pulse at 0 mV and ranged from 25–100 pF. Liquid junction potentials were
calculated using JPCalc (written by P. Barry, University of New South Wales,
1994) and subtracted.
Data analysis
Current (I) as a function of glycine concentration ([gly]) was ﬁtted by least-
squares minimization to
I=Imax ¼ ½gly=ðEC501 ½glyÞ; (1)
where Imax is the maximal current and EC50 the concentration of glycine that
generates a half-maximal current. To assess difference in means, analysis of
variance (ANOVA), with the appropriate post hoc test or Student’s t-test,
was preformed using Microsoft Excel or GraphPad Prism software (24).
Signiﬁcant differences (p, 0.05) are indicated in the ﬁgures accompanying
this article with an asterisk.
Modeling
A model was constructed of glycine accumulation in a CHO cell expressing
GLYT1b. The two main goals were to provide a quantitative description of
transporter function in our expression system, and to make predictions about
GlyT1b performance in other systems with different geometry, transporter
density, or solute gradients. It was necessary to set several model parameters
to arbitrary but reasonable values. Thus, some parameters, such as substrate
binding rate, are arbitrary, whereas others, such as substrate binding afﬁnity,
are constrained by the data and likely to be accurate. The transporters were
represented using a Markov reaction scheme, which describes transitions
between eight states. The model incorporated the buildup of glycine in the
ﬁnite intracellular volume of the CHO cell, and the slow diffusion of glycine
from the cellular compartment into the much larger volume of the patch
electrode. The cell was treated as a single, well-stirred compartment, with
a volume of Vcell liters, which can be determined from the cell radius, rcell,
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Vcell ¼ 1000 3 4=3p r3cell: (2)
The cell’s membrane capacitance (determined from a test pulse) was used
to estimate rcell. Speciﬁc membrane capacitance (Cm) is ;1 mF cm
2, but
the ‘‘apparent’’ value of this parameter can be distorted by membrane
foldings, which are not visible under light microscopy (25). A high density
of ﬁlopodia was observed on the surface of CHO cells under electron
microscopy (results not shown), so apparent Cm was set to 3 mF cm
2,
similar to the value obtained for HEK cells (25). For a GLYT1b transport
rate of Tgly molecules per second into the cell, the change of intracellular
glycine concentration D[gly] during a short time interval, Dt, is,
D½gly ¼ ðTglyDt=NAÞ=Vcell  ½glyKdiffusion:Dt; (3)
where NA is Avogadro’s number and Kdiffusion is the diffusion rate constant
(s1) from the cell to the patch electrode. The model was constructed using
AxoGraph 4.9 (Axon Instruments), and the results were independently
veriﬁed using the general-purpose modeling package, Berkeley Madonna.
Information about these programs can be found at www.axon.com/cn_
AxoGraph4.html and www.berkeleymadonna.com, respectively. Files im-
plementing the AxoGraph or Berkeley Madonna models are available on
request from John.Clements@anu.edu.au. Model parameters were system-
atically adjusted using a simplex algorithm to minimize the sum of squared
errors between simulated and recorded current transients. The GLYT1b
Markovmodel incorporated several simpliﬁcations and constraints to make it
physically plausible, and to keep the number of free parameters manageable.
Glycine and Na1 were assumed to bind in a narrow pore in the transporter,
such that Na1 binding precedes glycine binding to the extracellular
conformation, and Na1 unbinding precedes glycine unbinding from the
intracellular conformation (26). The binding and cotransport of Cl was not
included in themodel, because the concentration gradient was constant for all
experiments, and Cl binding/unbinding is not rate-limiting for inward
glycine transport (27). However, cotransport of Cl was considered when
calculating the transporter current, Igly, which is generated by the transfer of
one net positive charge per glycine molecule (one Cl with two Na1):
Igly ¼ Tgly : 1:6 3 1019: (4)
There was no information in the data about the binding rate of glycine, so
it was arbitrarily ﬁxed at 5 mM1 s1, similar to its binding rate at ligand-
gated receptors (28). Similarly, the Na1 binding and unbinding rates from
the intracellular site were arbitrarily ﬁxed at 1 mM1 s1 and 50,000 s1,
respectively, based on the observed sensitivity to intracellular Na1 for the
related GABA transporter (10). The forward turnover rate of the fully loaded
transporter (Na1 and glycine bound) was ﬁxed at 5 s1 based on data from
the related GABA and serotonin transporters (29–31), and the reverse
turnover rate was a free parameter. The forward and reverse turnover rates of
the unloaded transporter were both free parameters. The quality of the ﬁt was
not sensitive to doubling or halving any one of the values chosen for the
constrained reaction rate parameters (results not shown). Thus, if these
parameters were not constrained, they could drift to physically unreasonable
values during the ﬁtting procedure. In total, the model had eight free
parameters. Several observations conﬁrm that it was not overparameterized.
The optimum parameters showed relatively little cell-to-cell scatter, and the
results for a given data set were independent of the starting guess. Also, the
model was ﬁt to a pair of transients that required 10 separate parameters to
describe them, 5 parameters for each transient. These were inward current
amplitude, decay time constant, steady-state inward current, outward current
amplitude, and outward current decay time constant (see Fig. 8 C).
RESULTS
The presence of GLYT1b transporters in the stably trans-
fected CHO-GLYT1b cell line was conﬁrmed by examining
substrate-selective uptake, and sensitivity to the GLYT1
speciﬁc inhibitor NFPS. After exposure to 3H-glycine as
described in Methods, CHO-GLYT1b cells accumulated 11
times more (5.982 6 0.48 fmol/min/104 cells, n ¼ 6) 3H-
glycine than CHO-K1 cells (0.524 6 0.07 fmol/min/104
cells, n ¼ 6). Sarcosine (300 mM), a substrate of GLYT1
transporters, reduced 3H-glycine uptake by 796 2% (n¼ 6),
and NFPS (1 mM) completely inhibited GLYT1b mediated
3H-glycine uptake (Fig. 1 A).
Application of maximal doses of glycine (300 mM)
and sarcosine (300 mM) elicited inward currents in CHO-
GLYT1b cells (Fig. 1 B). The peak amplitude of the current
elicited by sarcosine is;80% of the amplitude of the current
induced by the same dose of glycine, consistent with pre-
vious reports in cell lines (32) and in oocytes (K. R. Aubrey,
P. Ju, and R. J. Vandenberg, unpublished data). The EC50 for
glycine was 16 6 5 mM (n ¼ 10, Fig. 1 C), which is
consistent with values obtained for GLYT1b expressed in
oocytes (33,34). The inward current elicited by saturating
glycine had an average amplitude of 18 6 2 pA (n ¼ 50,
range from 4 to 60 pA), and the largest transporter currents
were recorded 3 days after passage. Although we have
recorded a range of glycine transporter current amplitudes,
closer investigation of this data reveals that this range of
amplitudes is more a reﬂection of a range of cell sizes, as
opposed to changes in GLYT1b expression levels. Fig. 1 D
illustrates the correlation between whole-cell capacitance
and current amplitude recorded from n ¼ 15 cells.
Coapplication of NFPS with glycine resulted in a complete
block of the transport current (Fig. 2 A).
When glycine was applied to CHO-GLYT1b cells voltage
clamped at 0 mV, with no glycine added to the patch pipette,
an inward current developed rapidly and then relaxed toward
a steady-state level, referred to in the following as the sus-
tained current (Fig. 2 A). The relaxation of the inward current
is observed in other cell lines expressing GLYT1b (HEK
cells (35) and quail ﬁbroblast cells (K. R. Aubrey and R. J.
Vandenberg, unpublished data), as well as oocytes express-
ing GLYT1b (K. R. Aubrey, P. Ju, and R. J. Vandenberg,
unpublished data). When glycine was removed, the current
transiently overshot the baseline before relaxing back to the
baseline current level over several seconds (Fig. 2 A). The
transient outward current is referred to in the following as the
overshoot. It is observed to a variable extent in oocytes
(unpublished data) and has not been reported in GLYT1
transfected cell lines. Coapplication of glycine with NFPS
results in a characteristic slowly developing, irreversible
block (36) of both the inward and overshoot currents,
suggesting that the glycine transporter mediates the over-
shoot. Application of glycine or NFPS to untransfected
CHO-K1 cells did not elicit a current (data not shown),
conﬁrming that GLYT1b expression is required for both
inward and overshoot currents.
Other members of the Na1/Cl-dependent neurotransmit-
ter transporter family have constitutive, substrate-indepen-
dent leak currents that can be blocked by transport inhibitors
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(for example, GABA (GAT) (37), dopamine (38), and
serotonin (29) transporters); however, no leak currents or
uncoupled currents have been observed for GLYT1
(33,34,39). NFPS was applied to CHO-GLYT1b cells under
different experimental conditions, to rule out the possibility
that the overshoot or any other component of the glycine
activated currents were due to a leak current. These con-
ditions were: 5 mM [Na1]i and 150 mM [Na
1]e (n ¼ 5),
50 mM [Na1]i and 150 mM [Na
1]e (n ¼ 5, Fig. 2 B), or
50 mM [Na1]i and 50 mM [Na
1]e (n ¼ 3). Under each
of these conditions, the current measured during NFPS appli-
cation was not signiﬁcantly different from the baseline
current (ANOVA, data not shown), conﬁrming previous re-
ports that GLYT1b does not have a constitutive leak current.
Glycine transport by GLYT1b is Na1 dependent (5), and
the Na1 gradient across glial cell membrane in the central
nervous system may vary, depending on local activity levels
and other factors. We investigated the effects of altering
[Na1]e and [Na
1]i on GLYT1b function in CHO cells. With
5 mM [Na1]i and 150 mM [Na
1]e, application of saturating
glycine (300 mM) produced a sustained current amplitude
that was 686 5% of the peak current, and an overshoot cur-
FIGURE 1 Glycine transport currents in CHO cells transfected with
GLYT1b. (A) 3H-glycine uptake by CHO-GLYT1b cells (black bar); in the
presence of the competitive GLYT1 substrate sarcosine (300 mM, shaded
bar); and the GLYT1 speciﬁc inhibitor NFPS (1 mM, open bar) (n ¼ 6,
ANOVA). (B) A whole-cell patch-clamp recording at 0 mV of GLYT1b
mediated currents. Sarcosine (300 mM, shaded bar) elicits a current that is
smaller in amplitude than the current induced by glycine (300 mM, black
bar). (C) Glycine concentration-response curve for transport currents
mediated by CHO-GLYT1b cells voltage clamped at 0 mV. Glycine
transport currents were normalized to the maximal current of each cell and
ﬁtted to the Michaelis-Menten equation (n ¼ 10). (D) Correlation between
cell capacitance and peak current amplitude (n ¼ 15).
FIGURE 2 Characteristic features of glycine transport currents measured
in the presence and absence of NFPS. (A) Application of glycine (300 mM,
black bar) induces an inward current that decays to a sustained current.
When glycine is removed, the current rapidly decays and transiently
overshoots the baseline. When glycine is coapplied with NFPS (1 mM, open
bar), both the inward and overshoot currents are blocked. The internal and
external Na1 concentrations are indicated. Numbers mark the (1), baseline
current; (2), peak current; (3), sustained current; (4), overshoot current; and
(5), NFPS block of the overshoot current. (B) Glycine (black bar) induces an
inward current, but NFPS (open bar), applied in the absence of glycine, has
no effect on the baseline current.
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rent amplitude that was 19 6 3% of the peak inward current
(n¼ 12, Fig. 3 A). When [Na1]i was increased from 5 mM to
50 mM, the relative amplitude of the sustained current was
unchanged at 63 6 6% of peak, but the overshoot current
was enhanced to 40 6 6% of peak (n ¼ 9, Fig. 3 B).
Reducing [Na1]e from 150 mM to 50 mM further enhanced
the relative amplitude of the overshoot current to 606 6% of
peak, but again did not alter the sustained current, which was
63 6 4% of peak (n ¼ 10, Fig. 3 B). A bar graph of the
amplitude of the sustained and overshoot currents relative to
the amplitude of the peak current is presented in Fig. 3 C.
Note that the data presented in Fig. 3 A is from a different cell
than that presented in Fig. 3 B; thus their current amplitudes
are not directly comparable. In summary, the relative am-
plitude of the overshoot current was enhanced when [Na1]e
was decreased and [Na1]i was increased, suggesting that the
overshoot current results from reverse transport of accumu-
lated glycine.
If this hypothesis is correct, then the amount of glycine
accumulation in the cell should inﬂuence the amplitude of
the sustained and overshoot currents. This was investigated
in two ways: ﬁrst by altering the applied glycine concentra-
tion and second by altering the time that glycine was applied.
Peak and sustained inward currents and peak overshoot
current were measured at a range of applied glycine con-
centrations (Fig. 4 A). A standard pulse width of 15 s was
used for all applications, and the interpulse recovery period
was .60 s. Currents were recorded with 50 mM [Na1]i and
50 mM [Na1]e to enhance the relative amplitude of the
overshoot current. Glycine concentration-response curves
were constructed with current amplitudes normalized to the
peak inward current at 300 mM glycine (Fig. 4 B). The peak
current had an EC50 of 39 6 3 mM, which was higher than
the value obtained earlier (16 6 5 mM, Fig. 1 C) due to the
reduced [Na1]e (27,40). The sustained inward current had an
EC50 of 50 6 11 mM and saturated at 56 6 9% of the peak
current. The overshoot outward current had an EC50 of 486
5 mM and saturated at 76 6 3% of the peak current. The
EC50 values for the peak, sustained, and overshoot currents
do not differ signiﬁcantly (n ¼ 7, repeat measure ANOVA).
Peak and sustained inward currents and peak overshoot
currents were also measured in response to a ﬁxed concen-
tration of glycine (300 mM) over a range of application times
(5, 15, and 60 s; Fig. 5 A). Once again currents were recorded
with 50 mM [Na1]i and 50 mM [Na
1]e to enhance the
relative amplitude of the overshoot current, and the inter-
pulse recovery period was.60 s. When glycine was applied
for 5 s, the sustained current was 706 4% and the overshoot
43 6 16% of the peak current; when applied for 15 s, the
sustained current was 52 6 10% and the overshoot current
55 6 11% of the peak current; these values are not sig-
niﬁcantly different from those reported in Fig. 3. When
glycine was applied for 60 s, the amplitude of sustained
current was 31 6 16% and the overshoot 70 6 19% of the
peak current. The relative amplitude of the sustained and
overshoot current compared to peak current increased sig-
niﬁcantly (5 vs. 60 s) as the time of glycine exposure in-
creased. This data is presented in Fig. 5 B (n ¼ 3, repeat
measure ANOVA).
Based on the observation that GLYT1 does not mediate
any leak conductances and given that sustained net reverse
transport can be detected with NFPS, it should therefore be
possible to apply standard transporter equilibrium equations
to predict the behavior of the sustained outward current as
a function of the Na1 concentration gradient.
The equilibrium membrane potential (Vr) of GLYT1b can
be calculated from
Vr ¼ ðRT=ðnNa  nClÞFÞ:lnðð½Na1 nNae ½ClnCle ½GlyeÞ=
ð½Na1 nNai ½ClnCli ½GlyiÞÞ; (5)
where F ¼ Faraday constant, R ¼ gas constant, and T ¼ 298
K. [Cl]i ¼ 65 mM; [Cl]e ¼ 170 mM. nNa and nCl are the
number of Na1 and Cl ions coupled to the transport of each
glycine molecule (2 and 1, respectively). Setting [Gly]i to
2 mM, [Gly]e to 1 mM, [Na
1]i to 5 mM, and [Na
1]e to
150 mM, the predicted equilibrium potential Vr is14 mV. If
the Na1 gradient is reduced by lowering [Na1]e to 50 mM,
the predicted Vr changes to 52 mV. Therefore, when the
glycine gradient and [Na1]i are as described above, net re-
FIGURE 3 Amplitude of overshoot current is
enhanced by depletion of the Na1 gradient.
Extracellular application of glycine stimulates an
inward current (300 mM, black bar). (A) A
glycine transport current recorded with 5 mM
[Na1]i and 150 mM [Na
1]e (striped bar) and (B)
a different cell with 50 mM [Na1]i and either
150 mM or 50 mM (shaded bar) [Na1]e. (C)
Bar graph of the sustained (black bars) and over-
shoot (open bars) current amplitudes as a percent-
age of peak current recorded in various Na1
gradients (n $ 10, ANOVA).
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verse transport should be detected when CHO-GLYT1b cells
clamped at 0 mV have 50 mM [Na1]e, but not at 150 mM
[Na1]e. This predictionwas tested experimentally. In 150mM
[Na1]e, stepping from 1 mM to 300 mM, glycine elicited
an inward current (Fig. 6 A). Changing the extracellular
solution to 50 mM [Na1]e produced a large outward shift in
the baseline current, and extracellular glycine application
again elicited an inward current. This glycine-elicited inward
current appears larger in amplitude than the current stim-
ulated by glycine in 150 mM [Na1]e, indicating that the
inward glycine current in 50 mM [Na1]e results from a
combination of glycine inhibition of the reverse transport
current and glycine stimulation of forward glycine transport.
Application of NFPS in 50 mM [Na1]e and 1 mM [gly]e
induced a slowly developing inward current, consistent with
progressive block of a substantial and sustained reverse
transport current. However, when the [Na1]e was switched
back to 150 mM the baseline current was not altered by
the application of NFPS (Fig. 6 A). This illustrates that at
0 mV, reverse transport occurs in 50 mM [Na1]e, but not in
150 mM [Na1]e. This observation is consistent with the
predictions of Eq. 1 and a summary of these results are
presented in Fig. 6 B.
Sustained reverse transport was seen in oocytes expressing
GLYT1b when their intracellular glycine concentration was
adjusted to 16 mM (5). This result was replicated in our study
by patch clamping CHO-GLYT1b cells with 16 mM glycine
in the pipette solution. When NFPS (1 mM) was applied,
a slowly developing inward current was seen (Fig. 6 C).
Reducing [Na1]e and increasing [Na
1]i, enhanced the rel-
ative amplitude of the reverse transport current blocked by
NFPS (Fig. 6 D). This result is similar to data presented
earlier (Fig. 3 C), conﬁrming that the overshoot arises from
reverse transport through GLYT1b.
A concentration-response curve was constructed by al-
tering [gly]i and measuring the amplitude of the outward
current blocked by NFPS. The irreversible nature of NFPS
meant that only one [gly]i concentration could be tested per
cell. All recordings were made 2 or 3 days after passage, with
5 mM [Na1]i and 50 mM [Na
1]e. Each data point represents
data from n $ 5 cells. The intracellular glycine EC50 for
reverse transport through GLYT1b was estimated to be
4.3 6 0.6 mM (Fig. 7).
We investigated the factors determining the kinetic prop-
erties of the inward, sustained, and overshoot currents in
CHO-GLYT1b cells. Identifying these factors may provide
insights into glycine dynamics in glia. A model of transporter
function was constructed (see Methods), which accurately
predicts the current transient elicited by glycine under a
variety of experimental conditions. It assumed that Na1 and
glycine bind sequentially inside a narrow pore in GLYT1b
(Fig. 8 A). This assumption gives rise to an eight-state
Markov reaction scheme describing GLYT1b function (Fig.
8 B), which was combined with a model of glycine dynamics
in a CHO cell coupled to a patch pipette. Free parameters
were systematically adjusted using a simplex algorithm, until
an optimal ﬁt to two different current transients was ob-
tained. The two transients were recorded in the same cell
with 50 mM [Na1]i and either 50 or 150 mM [Na
1]e. They
were elicited by a glycine pulse (300 mM, 30 s). The free
parameters were the number of transporters, the diffusion
rate from the cell into the patch electrode, and the six reaction
rates indicated in Fig. 8 B. After parameter optimization, the
model accurately predicted the complex, multiexponential
inward and outward currents recorded under two different
experimental conditions. As expected, there was consider-
able cell-to-cell variability in the number of transporters
(from 1.2 3 107 to 8.5 3 107, n ¼ 5), and the diffusion rate
FIGURE 4 Amplitude of the peak, sustained, and overshoot currents is
dependent on the extracellular glycine concentration. (A) Currents stim-
ulated by increasing [glycine]e with 50 mM [Na
1]i and 50 mM [Na
1]e. (B)
Concentration-response curves for the peak (n), sustained (d), and overshoot
(e) currents normalized to the Imax of the peak current and ﬁtted to the
Michaelis-Menten equation (n¼ 7). The EC50 values for the peak, sustained,
and overshoot currents were not signiﬁcantly different (repeat measure
ANOVA).
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(0.007 to 0.047 s1), most likely reﬂecting geometric
differences between cells. Consistent with this, the estimated
transporter density showed less variability (3200–8500
mm2), and the amplitude of currents stimulated by gly-
cine (300 mM) from cells recorded with 50 mM [Na1]i and
50 mM [Na1]e correlated strongly with cell capacitance (Fig.
1 D). The optimum reaction rates for the free parameters
were: loaded transporter turnover rate ﬁxed at 5 s1, reverse
rate 50 6 7 s1; unloaded turnover rate 46 6 8 s1, reverse
rate 72 6 15 s1; glycine unbinding rate from the extra-
cellular conformation 30 6 5 s1, and from the intracellular
conformation 4800 6 400 s1; Na1 unbinding rate from the
extracellular conformation 140,000 6 20,000 s1 (n ¼ 5).
As an independent test of the model, the optimum pa-
rameters obtained from each cell, was used to simulate
responses to a range of glycine concentrations, and con-
centration-response curves were constructed. Simulations
were performed for two different Na1 gradients. Setting
[Na1]e to 150 mM and [Na
1]i to 5 mM gave a predicted
EC50 of 14 6 2 mM (n ¼ 5), which is consistent with
the experimentally observed EC50 of 16 6 5 mM
(Fig. 1 C). With 50 mM [Na1]e and 50 mM [Na
1]I, an
EC50 of 43 6 6 mM was obtained, also consistent with the
observed EC50 of 39 6 3 mM (Fig. 4 B). These theoretical
estimates of EC50 were generated purely from kinetic
information, as the current transients used in the ﬁtting pro-
FIGURE 5 Amplitude of the sustained and
overshoot currents is dependent on the time
of glycine application. (A) Currents stimu-
lated by 300 mM [glycine]e with 50 mM
[Na1]i and 50 mM [Na
1]e applied for 5, 15,
and 60 seconds (B) Bar graph of the sustained
(black bars) and overshoot (open bars)
current amplitudes as a percentage of peak
current recorded for each of the time periods
glycine was applied (n ¼ 3; repeat measure
ANOVA).
FIGURE 6 Elevating [glycine]i stimulates an
outward current that can be blocked with NFPS.
(A) When the glycine and [Na1]i gradients are
set as described on the ﬁgure, glycine (300 mM,
black bar) stimulates an inward current in
150 mM [Na1]e (striped bar) and 50 mM
[Na1]e (gray bar). NFPS (1 mM, open bar) blocks
a current in 50 mM [Na1]e, but does not block
a current in 150 mM [Na1]e (compare the baseline
current at 150 mM [Na1]e before NFPS application
and then after switching from 50 mM [Na1]e to
150 mM [Na1]e as NFPS inhibition of GLYT1b
persists after washout of free drug (see Fig. 2 B)).
(B) Bar graph comparing the amplitude of the
NFPS blocked currents in 150 mM and 50 mM
[Na1]e. (n ¼ 4, paired Student’s t-test). (C) When
[glycine]i is 16 mM, NFPS (1 mM, open bar)
blocks a sustained outward current. (D) The
amplitude of the NFPS blocked current was
enhanced by elevating [Na1]i and lowering
[Na1]e (n $ 4).
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cedure were obtained at a single saturating concentration of
glycine.
DISCUSSION
The small electrogenic currents generated by transporters are
typically studied in Xenopus oocytes, because their efﬁcient
protein expression and large membrane surface area make
the currents relatively easy to detect and measure. However,
the large size of the oocyte slows solution exchange and
alters the kinetics of the response. Here we demonstrate that
GLYT1b transport currents can be studied in a mammalian
cell line, where results can be interpreted more conﬁdently.
Stably transfected CHO-GLYT1b cells express up to 108
functional GLYT1b per cell, permitting electrogenic trans-
port currents to be measured with an excellent signal/noise
ratio. Furthermore, rapid solution exchange (;100 ms) can
be achieved at the surface of these small cells, permitting
detailed kinetic analysis of transporter currents.
When extracellular glycine was applied to whole-cell
patch-clamped CHO-GLYT1b cells, a transporter-speciﬁc
inward current was stimulated. The inward transport current
rapidly relaxed to a sustained current and, when glycine was
removed from the extracellular recording solution, a transient
overshoot current was observed. We hypothesized that the
relaxation of the GLYT1b current was due to intracellular
glycine accumulation, and that the overshoot current was due
to reverse transport of the accumulated glycine. Consistent
with this interpretation, the amplitude of the sustained and
overshoot currents was dependent on the Na1 gradients (Fig.
3) and were altered as predicted in conditions that changed
the concentration of accumulated glycine (Figs. 4 and 5). Net
reverse transport was stimulated by adding glycine to the
patch pipette and shown to behave as predicted by standard
transporter equilibrium equations (Fig. 6). A reverse trans-
port concentration-response curve was then constructed
(Fig. 7), which indicates that the glycine EC50 for reverse
glycine transport by GLYT1b is ;4.3 6 0.6 mM, similar to
previous reports for the GABA transporter (10). Based on
these data, a model of GLYT1b function was constructed.
The time course of the response of a CHO-GLYT1b cell to
a long pulse of glycine can be explained in terms of this
model of transporter function (Fig. 8, B and C).
Kinetics properties of GLYT1b
During continued application of glycine, the inward current
decays exponentially as glycine accumulates in the CHO cell.
The reduction in current is caused by rebinding of glycine to
the transporter in the intracellular conformation, which slows
recycling of the transporter to the extracellular conformation
(via the Ti/ Te pathway), and accelerates reverse glycine
transport (via the TiNa2Gly/ TeNa2Gly pathway). If the
CHO cell were a sealed system, the current would decay to
zero. However, intracellular glycine diffuses into the large
sink provided by the recording electrode, and the current
decays to a sustained level that is determined by the rate of
diffusion. Thus, the sustained inward glycine transport is
a recording artifact attributable to the patch electrode, and
would not be present in an intact CHO-GLYT1b cell or glial
cell. Glial cells are typically smaller and have many more
small diameter processes than CHO cells, suggesting that
GLYT1 mediated uptake may decay rapidly to zero in vivo
during periods of strong or sustained glycinergic drive.
The diffusion time constant for the decay of the peak
current to the sustained current recorded in CHO-GLYT1b
cells ranged from 20 s to 150 s, which is in good agreement
with other estimates (range 10–100 s) (41,42). The diffusion
time constant (¼ 1/Kdiffusion) should be approximately
proportional to series resistance, as both are limited by the
inside diameter of the patch electrode, and should be
proportional to cell volume. We plotted 1/Kdiffusion from
each of the ﬁve analyzed cells versus series resistance mul-
tiplied by estimated volume of each cell (result not shown).
The expected trend was apparent, but the correlation was
not statistically signiﬁcant.
When glycine is washed off a CHO-GLYT1b cell after
a long pulse, a transient outward current is observed. We
carefully characterized the overshoot current, and demon-
strated that it is most likely to result from reverse transport
of accumulated glycine through GLYT1b, consistent with
previous observations using the oocyte expression system
(5). The theoretical model accurately predicts the amplitude
and time course of the overshoot current under a range of
recording conditions. Decreasing [Na1]e increases the
amplitude of the overshoot current and accelerates its decay.
FIGURE 7 Intracellular glycine concentration-response curve for reverse
transport by GLYT1b. The amplitude of the NFPS blocked reverse transport
current was measured as in Fig. 6 C, in the presence of 50 mM [Na1]e and
5 mM [Na1]i, across a range of internal glycine concentrations (0–48 mM).
Raw GLYT1b reverse transport currents were ﬁtted with the Michaelis-
Menten equation (n $ 5).
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This observation can also be explained in terms of the model
(Fig. 8 B). When [Na1]e is reduced, the transporter spends
less time in the states with Na1 bound (TeNa, TeNa2), and
more time in the unbound state (Te). This promotes the
transition Te / Ti, which increases the availability of
transporters in the intracellular conformation and enhances
reverse transport (TiNa2Gly / TeNa2Gly). Faster reverse
transport accelerates the depletion of the accumulated gly-
cine, so the initially larger overshoot decays more rapidly. The
model conﬁrms that the overshoot current is consistent with
reverse transport of accumulated glycine through GLYT1b.
The model predicts that reverse transport occurs faster
(50 s1) than inward transport (ﬁxed at 5 s1). If correct, then
at equilibrium when [glycine]e is very low, GLYT1 will be
oriented in the extracellular conﬁguration most of the time.
As a result, the number of transporters available to bind re-
leased glycine will be optimized for efﬁcient removal of
glycine from the synapse.
When glycine is applied, an inward current develops with
a 20–80% rise time of 110 6 8 ms (n ¼ 8). In contrast, the
model predicts that the response to an instantaneous step into
glycine (300 mM) will have a 20–80% rise time of only 5 ms,
suggesting that solution exchange at the cell membrane is
rate limiting for transporter activation in our experiments.
Our model supports the suggestion that GLYT1b in astrocyte
processes proximal to inhibitory synapses will rapidly clear
synaptically released glycine.
We carefully examined several alternative reaction schemes
but rejected them, as they were not consistent with the data.
A scheme based on the assumption that glycine binding must
precede Na1 binding accurately ﬁt the two transients
recorded in 50 and 150 mM [Na1]e, but when the optimally
ﬁtted model was used to generate a concentration-response
curve for glycine, the predicted EC50 was more than an order
of magnitude too low (results not shown). If we assumed that
the binding of Na1 and glycine occurs at two independent,
noninteracting sites, the reaction scheme did not accurately
ﬁt the two transients. The preferred model (Fig. 8) is subject
to all the usual caveats applied to Markov schemes. Several
reaction rates could not be determined from our data, and
were constrained to values determined in studies of closely
related transporter proteins. This may introduce small sys-
tematic errors into our free parameter estimates. The model is
FIGURE 8 A model of glycine transport by GLYT1b. (A) Schematic
showing glycine (G) and Na1 (1) binding sequentially in a narrow pore.
Na1 binds before glycine to the extracellular conformation and is ﬁrst to
unbind from the intracellular conformation of the transporter. (B) Markov
model of GLYT1b function; all reaction rates are given in s1 unless
indicated in the ﬁgure. Some reaction rates were constrained, but others were
determined by ﬁtting two separate responses to a pulse of glycine, one
obtained in 50 mM [Na1]e, and the other in 150 mM [Na
1]e. Unconstrained
reaction rates are shown in bold italics with asterisks. (C) A typical ﬁt
obtained with the model (shaded line) of experimental data (dotted line) in
two conditions, with 50 mM [Na1]i and either 150 mM or 50 mM [Na
1]e.
Fit parameters can be found in the Methods (ﬁxed parameters) and Results
sections (variable parameters). (D) Independent veriﬁcation of the model
was obtained by using the model to predict the glycine concentration-
response curve with 50 mM [Na1]i and 50 mM [Na
1]e (d), and with 5 mM
[Na1]i and 150 mM [Na
1]e (n). The predicted curves are in good agreement
with experimental results (presented in Figs. 1 C and 4 B).
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a pragmatic simpliﬁcation of the kinetic and pharmacolog-
ical properties of GLYT1b. It effectively summarizes the
main features of the transporter’s dynamic behavior. The
model is particularly useful for exploring the experimental
results more deeply and for extrapolating beyond them to
other scenarios.
Comparison with GABA transporters
Reverse transport currents mediated by GABA transporters
(GAT) have been observed in expression systems and native
preparations (10,37,43,44), and have similar properties to
those reported here for GLYT1b. GAT-mediated reverse
transport is dependent on intracellular GABA, Na1, and Cl,
and reverse transport is faster at positive potentials. The EC50
for intracellular GABA binding was 2 mM at 0 mV (10). Our
experimental and theoretical results suggest a similar in-
tracellular EC50 for glycine at GLYT1b. We also found that
the intracellular Na1 binding site is not saturated at 5 mM,
because increasing [Na1]i to 50 mM enhanced the overshoot
current. GAT also has a very high intracellular EC50 for Na
1
of 54.6 mM (10). The similar pharmacological and func-
tional properties of GAT and GLYT1b suggest that they may
play similar roles at inhibitory synapses. The kinetic prop-
erties of GLYT1b imply that, depending on the density of
transporter in the membrane and the intracellular volume in
which glycine accumulates; they may regulate excitatory
synaptic function on the subsecond timescale.
Physiological roles of GLYT1 in vivo
In this report, we have presented a plausible model for GLYT1
function based on biophysical studies of GLYT1b expressed
in CHO cells. In the following section, we will discuss the
signiﬁcance of this work in terms of understanding the GLYT1
function in vivo. Transporter function can sometimes be
sensitive to expression levels in recombinant experimental
systems (45). The model estimates that the density of GLYT1
expression in CHO-GLYT1b cells is between 3200mm2 and
8500 mm2. GLYT1b transporter density has not been
measured in vivo, but the density of GABA transporters has
been estimated at 800–1300 mm2 in mouse cerebellum and
hippocampal presynaptic boutons (46), and the density of
glutamate transporters has been estimated at 2300 mm2 and
8500 mm2 in astrocytes of the hippocampus and cerebellum,
respectively (47). These in vivo values are similar to our
estimates of the GLYT1b density in CHO-GLYT1b cells
(3200–8500 mm2). GLYT1 transport currents recorded from
mouse Bergmann glial cells are of similar amplitude to those
measuredhere, suggestingahighdensity ofGLYT1expression
in this in vivo preparation (13).
We can conﬁdently extrapolate from the biophysical prop-
erties of GLYT1b observed in this study to predict GLYT
function in vivo. The cell volume of astrocytes and other glia
is smaller than CHO-GLYT1b cells (diameter 20–40 mm),
resulting in faster glycine accumulation for a given GLYT
density. Furthermore, the kinetics of glycine accumulation
and efﬂux will be even faster in the microenvironment of
the abundant low-diameter processes that project from the
astrocyte cell body, due to their high surface area/volume
ratio (48). Finally, GLYT kinetics will be faster in vivo at
37C compared to our room-temperature experiments (49).
Thus, the general characteristics of the transport currents
observed in this study, including rapid saturation and transient
reverse transport, are almost certain to occur in vivo. In
microscopic domains of the brain and spinal cord, the kinet-
ics of glycine accumulation and efﬂux are likely to be signif-
icantly faster than observed in this study, and may occur on
a subsecond timescale.
Our ﬁndings demonstrate that GLYT1b is capable of
mediating glycine release as well as glycine uptake in mam-
malian cells. The release of accumulated glycine has the
potential to modulate synaptic function. For example, a sus-
tained period of inhibitory synaptic activity may saturate
GLYT1 uptake due to accumulation of glycine in the low-
diameter processes that project from glial cells and surround
the synapse. This would lead to local extracellular build up
of glycine, which would then spill over to nearby excitatory
synapses and enhance NMDAR sensitivity. When inhibitory
activity decreases, the accumulated glycine may be released
from glia via reverse transport, thereby prolonging the en-
hancement of NMDAR sensitivity.
The reversal potential for GLYT1b in astrocytes under
resting physiological conditions is estimated at between65
and 95 mV (50,51), and astrocyte resting membrane po-
tential is approximately 80 mV (52). So GLYT1b operates
close to its reversal potential. Activation of any of the receptor-
gated ion channels known to be expressed in astrocytes, may
change their resting membrane potential and alter GLYT1b
function. Similarly, changes in intracellular Na1 or Cl
concentration may shift the reversal potential of GLYT1b,
causing functional changes. For example, pathological states
may elevate [Na1]i (53,54), which would stimulate glycine
release and thereby increase neurotoxic NMDAR activation.
Reverse transport of glycine may also play a role at
inhibitory synapses. It is hypothesized that at times of low
synaptic activity, GLYT1 releases glycine from glial cells
surrounding the synapse, which is taken up by GLYT2 on
postsynaptic neurons for packaging into vesicles (6,55).
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